QuidelOrtho Corporation


QuidelOrtho is a leading diagnostics company dedicated to advancing healthcare through innovative solutions in immunoassay, molecular testing, clinical chemistry, and immunohematology. With a mission to improve health and transform lives, they provide vital health information across the care continuum, from home to hospital, lab to clinic. The company is committed to sustainability, innovation, and delivering accurate, reliable results to support community health worldwide.

Industries

biotechnology
health-care
manufacturing
pharmaceutical

Nr. of Employees

Very Large (1000+)

QuidelOrtho Corporation

San Diego, California, United States, North America


Products

Multiplex real-time PCR testing platform

Instrument platform for multiplex real-time PCR designed to support syndromic molecular testing in decentralized and near‑patient settings.

Rapid lateral-flow diagnostic tests

Rapid lateral-flow immunoassays intended for decentralized, rapid-result diagnostic screening and triage.

Integrated immunoassay and chemistry analyzer family

High-performance integrated analyzers providing combined chemistry and immunoassay testing with reagent handling, built-in automated checks (e.g., clot/bubble detection) and consumable formats intended to reduce maintenance.

Automated and semi-automated immunohematology testing platforms

Automated pretransfusion testing systems and semi-automated reader solutions that combine column agglutination assay formats with camera-based readers to automate grading, interpretation and data routing to laboratory systems.

Specimen collection swabs and transport media

Flocked swab collection devices and universal transport media designed to maximize specimen recovery and preserve viability during transport to testing laboratories.

Benchtop point-of-care analyzers and associated assays

Small-footprint benchtop analyzers and matched assays for near-patient testing workflows, enabling rapid turnaround and simplified operation in decentralized clinical settings.

View All Products

Services

Consulting to assess lab performance, identify marginal gains, and implement data-driven improvements to capacity and workflows.

Server-based software for instrument integration, result management, QC tracking and workflow standardization across networks of instruments, with features to maintain access during LIS outages.

Structured customer-experience and support services including proactive maintenance, remote diagnostics, and 24/7 assistance.

Expertise Areas

  • Clinical laboratory automation
  • Immunoassay and clinical chemistry systems
  • Molecular diagnostics and PCR assay development
  • Immunohematology and donor-screening testing
  • Show More (6)

Key Technologies

  • Real-time multiplex PCR
  • Lateral-flow immunoassays
  • Column agglutination immunohematology
  • Integrated immunoassay and chemistry analyzers
  • Show More (9)

News & Updates

The company reported its financial results for Q3 2023.

The company announced preliminary revenue results for Q3 2023.

The company will participate in the Evercore ISI Conference.

The company will participate in the William Blair 43rd Annual Growth Stock Conference.

The company received FDA De Novo classification for two SARS-CoV-2 antibody tests.

The company will report its Q2 2023 financial results.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.